Cargando…
Basal cell adenocarcinoma of the supraglottic larynx: treatment of recurrent disease with tamoxifen
At the age of 83, a woman presented with an extremely rare cancer, basal cell adenocarcinoma (BCAC) of the supraglottic larynx. Pathology revealed a stage IVA tumor, pathological stage T4N0M0. She was treated with surgery and did not receive any adjuvant chemotherapy or radiation therapy. At the age...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PAGEPress Publications
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282460/ https://www.ncbi.nlm.nih.gov/pubmed/22355510 http://dx.doi.org/10.4081/rt.2011.e55 |